PPARα gene polymorphisms modulate the association between physical activity and cardiometabolic risk

Area of Science:

• Genetics
• Metabolic Health
• Cardiovascular Disease Prevention

Background:

• Habitual physical activity (PA) is recognized for preventing type 2 diabetes and cardiovascular disease.
• Individual responses to PA vary, suggesting underlying genetic and metabolic factors.
• The proliferator-activated receptor-alpha (PPARα) gene influences metabolism, vascular function, and inflammation, making it a candidate for mediating PA responses.

Purpose of the Study:

• To investigate how variations in the PPARα gene interact with physical activity levels.
• To determine if PPARα gene variations predict an individual's overall cardiometabolic risk (CMR) profile.
• To explore the extent to which PPARα genetic variation modifies the cardiometabolic benefits of physical activity.

Main Methods:

• Cross-sectional study of 917 community volunteers (aged 30-54 years).
• Genotyping for 5 single nucleotide polymorphisms in the PPARα gene to define common haplotypes.
• Calculation of a continuous cardiometabolic risk (CMR) score based on waist circumference, blood pressure, triglycerides, HDL-cholesterol, and glucose.

Main Results:

• One common PPARα haplotype (H-23) was associated with increased CMR.
• The association between the H-23 haplotype and CMR was moderated by daily physical activity.
• Higher physical activity levels were linked to a greater reduction in CMR among individuals carrying the H-23 haplotype.

Conclusions:

• Variations in the PPARα gene appear to modulate the cardiometabolic effects of physical activity.
• The PPARα gene may influence the degree to which individuals benefit from physical activity in managing cardiometabolic risk.
• Genetic factors, such as PPARα variations, can interact with lifestyle choices like physical activity to impact health outcomes.